A new method of reversing Alzheimer's shows promise in an animal study, as researchers at University Hospitals restore brain energy molecule NAD+.

New York reports record flu surge with over 71,000 cases in one week - the highest since tracking began in 2004. Health officials urge vaccination.

Brazilian plant Joseph's Coat shows promise for arthritis treatment in new lab studies, reducing inflammation and protecting joints safely in research.

Holiday stress wreaked havoc on your gut? Experts share six simple ways to reset digestion at home, from better sleep routines to fiber-rich meals.

New research reveals exercise may reprogram heart-controlling nerves, giving hope for potentially better treatments for conditions such as irregular rhythms and chest pain.

The Fox News Health Newsletter brings you trending and important stories about healthcare, drug developments, mental health issues, real people's triumphs over medical struggles, and more.

Discover 2025's hottest fitness trends, from TikTok's viral 12-3-30 workout to weighted vest training and more. Experts weigh in on whether they live up to the hype.

A new study reveals older adults on six or more medications struggle more during rehabilitation recovery, especially those over 80 seeking independence.

Research from 2025 shows vitamin D supplements, transcendental meditation, GLP-1 drugs and creative activities can significantly slow aging and extend lifespan.

Study finds widely prescribed opioid painkiller tramadol shows limited effectiveness for chronic pain while increasing risk of serious cardiovascular harm.

A highly contagious flu mutation called subclade K is sweeping the nation, raising health concerns about vaccine effectiveness this season. Here are the states at most risk.

Former Senator Ben Sasse announced his stage 4 pancreatic cancer diagnosis in 2025, calling it "a death sentence" while vowing to fight the disease.

The FDA has approved the first-ever Wegovy pill for weight loss, with the oral GLP-1 offering a 16.6% average weight reduction as a needle-free alternative.

Timing matters: Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.